186 related articles for article (PubMed ID: 33793366)
21. Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials.
Caparica R; Bruzzone M; Hachem GE; Ceppi M; Lambertini M; Glasberg J; de Azambuja E; Van Laethem JL; Hendlisz A
Crit Rev Oncol Hematol; 2020 May; 149():102940. PubMed ID: 32252001
[TBL] [Abstract][Full Text] [Related]
22. The Landmark Series: Gallbladder Cancer.
Gamboa AC; Maithel SK
Ann Surg Oncol; 2020 Aug; 27(8):2846-2858. PubMed ID: 32474816
[TBL] [Abstract][Full Text] [Related]
23. The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis.
Hamura R; Haruki K; Taniai T; Yanagaki M; Shirai Y; Furukawa K; Usuba T; Fujioka S; Okamoto T; Nakabayashi Y; Uwagawa T; Ikegami T
Int J Clin Oncol; 2022 Jul; 27(7):1188-1195. PubMed ID: 35426581
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.
Lim KH; Oh DY; Chie EK; Jang JY; Im SA; Kim TY; Kim SW; Ha SW; Bang YJ
BMC Cancer; 2009 Sep; 9():345. PubMed ID: 19781103
[TBL] [Abstract][Full Text] [Related]
25. [Management of biliary tract carcinomas].
Delbaldo C; Laurent A; Grenier J; Cherqui D; Luciani A; Piedbois P
Rev Prat; 2009 Apr; 59(4):469-73. PubMed ID: 19462864
[TBL] [Abstract][Full Text] [Related]
26. Outcome of adjuvant therapy in biliary tract cancers.
McNamara MG; Walter T; Horgan AM; Amir E; Cleary S; McKeever EL; Min T; Wallace E; Hedley D; Krzyzanowska M; Moore M; Gallinger S; Greig P; Serra S; Dawson LA; Knox JJ
Am J Clin Oncol; 2015 Aug; 38(4):382-7. PubMed ID: 24572429
[TBL] [Abstract][Full Text] [Related]
27. Biliary tract cancers: SEOM clinical guidelines.
Benavides M; Antón A; Gallego J; Gómez MA; Jiménez-Gordo A; La Casta A; Laquente B; Macarulla T; Rodríguez-Mowbray JR; Maurel J
Clin Transl Oncol; 2015 Dec; 17(12):982-7. PubMed ID: 26607930
[TBL] [Abstract][Full Text] [Related]
28. Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review.
Yoo C; Shin SH; Park JO; Kim KP; Jeong JH; Ryoo BY; Lee W; Song KB; Hwang DW; Park JH; Lee JH
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916008
[TBL] [Abstract][Full Text] [Related]
29. Indications for neoadjuvant, adjuvant, and palliative chemotherapy in the treatment of biliary tract cancers.
Huitzil-Melendez FD; O'Reilly EM; Duffy A; Abou-Alfa GK
Surg Oncol Clin N Am; 2009 Apr; 18(2):361-79, x. PubMed ID: 19306817
[TBL] [Abstract][Full Text] [Related]
30. Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas.
Saito H; Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Kondo S; Furuse J; Tsuyuguchi T; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Amano H; Miura F; ; ;
J Hepatobiliary Pancreat Surg; 2008; 15(1):63-8. PubMed ID: 18274845
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.
Knight G; Earle CC; Cosby R; Coburn N; Youssef Y; Malthaner R; Wong RK;
Gastric Cancer; 2013 Jan; 16(1):28-40. PubMed ID: 22467061
[TBL] [Abstract][Full Text] [Related]
33. Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer.
Jensen LH
Expert Opin Investig Drugs; 2016; 25(3):359-65. PubMed ID: 26781267
[TBL] [Abstract][Full Text] [Related]
34. [Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer].
Scheufele F; Friess H
Chirurg; 2020 May; 91(5):391-395. PubMed ID: 31965198
[TBL] [Abstract][Full Text] [Related]
35. ADJUBIL: phase II study of adjuvant immunotherapy with STRIDE regimen with/without capecitabine in biliary tract cancers.
Goetze T; Gonzalez-Carmona MA; Kochen L; Agaoglu NB; Al-Batran SE; Habibzada T; Pons M; Brunner M; Ettrich TJ; Köhne CH; Roderburg C; Modest D
Future Oncol; 2024 Feb; 20(6):307-315. PubMed ID: 38410920
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma.
Motoi F; Unno M
Jpn J Clin Oncol; 2020 May; 50(5):483-489. PubMed ID: 32083290
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial.
Labori KJ; Lassen K; Hoem D; Grønbech JE; Søreide JA; Mortensen K; Smaaland R; Sorbye H; Verbeke C; Dueland S
BMC Surg; 2017 Aug; 17(1):94. PubMed ID: 28841916
[TBL] [Abstract][Full Text] [Related]
38. New developments in systemic therapy for advanced biliary tract cancer.
Morizane C; Ueno M; Ikeda M; Okusaka T; Ishii H; Furuse J
Jpn J Clin Oncol; 2018 Aug; 48(8):703-711. PubMed ID: 29893894
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant therapy of biliary tract cancers.
Kefas J; Bridgewater J; Vogel A; Stein A; Primrose J
Ther Adv Med Oncol; 2023; 15():17588359231163785. PubMed ID: 37007632
[TBL] [Abstract][Full Text] [Related]
40. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
